CHEBI:75043 - Breo Ellipta

ChEBI IDCHEBI:75043
ChEBI NameBreo Ellipta
Stars
DefinitionA mixture composed of vilanterol trifenate and fluticasone furoate (trade name Breo Ellipta) that is used for treatment of bronchospasm associated with chronic obstructive pulmonary disease.
Last Modified31 July 2013
SubmitterSteve
Wikipedia
Roles Classification
Biological Role:
beta-adrenergic agonist  An agent that selectively binds to and activates β-adrenergic receptors.
Applications:
beta-adrenergic agonist  An agent that selectively binds to and activates β-adrenergic receptors.
anti-asthmatic drug  A drug used to treat asthma.
bronchodilator agent  An agent that causes an increase in the expansion of a bronchus or bronchial tubes.
anti-allergic agent  A drug used to treat allergic reactions.
ChEBI Ontology
Outgoing Relation(s)
Breo Ellipta (CHEBI:75043) has part fluticasone furoate (CHEBI:74899)
Breo Ellipta (CHEBI:75043) has part vilanterol trifenate (CHEBI:75040)
Breo Ellipta (CHEBI:75043) has role anti-allergic agent (CHEBI:50857)
Breo Ellipta (CHEBI:75043) has role anti-asthmatic drug (CHEBI:49167)
Breo Ellipta (CHEBI:75043) has role bronchodilator agent (CHEBI:35523)
Breo Ellipta (CHEBI:75043) has role β-adrenergic agonist (CHEBI:35522)
Breo Ellipta (CHEBI:75043) is a mixture (CHEBI:60004)
Synonyms  Source
fluticasone furoate/vilanterolChEBI
fluticasone furoate/vilanterol trifenateChEBI
Manual XrefsDatabases
Fluticasone_furoate/vilanterolWikipedia
Citations